Nuwellis Inc is a medical technology company focused on developing innovative solutions for treating fluid overload in patients, specifically targeting those with heart failure and other conditions that lead to the accumulation of excess fluid. The company’s flagship product is designed to enhance the process of fluid removal through a unique approach that combines advanced technology with user-friendly operation, aiming to improve patient outcomes and quality of life. By harnessing cutting-edge medical advancements, Nuwellis strives to offer safer and more effective treatment options for patients who struggle with the complications associated with fluid retention. Read More
Stay up-to-date with the latest market trends one hour before the close of the markets on Monday. Explore the top gainers and losers during today's session in our detailed report.
As the regular session of the US market concludes on Friday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
The FDA and Nuwellis warn of potential risks linked to AquaFlexFlow UF 500 Plus blood circuits. A recall addresses issues like therapy termination and patient injury risks.
